Adoptive cell therapy

This page covers all Adoptive cell therapy drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting CD19.

Targets

CD19

Marketed (1)

• IL-2 pre-treated CD19 cells · jiangjingting · Oncology
  IL-2 pre-treated CD19-targeted cells enhance immune recognition and elimination of CD19-expressing B-cell malignancies through cytokine-primed cellular immunity.

Phase 2 pipeline (1)

• CIK Cell · Chuan An Biotechnology Co., Ltd. · Oncology
  CIK cells are a type of adoptive cell therapy that stimulate the immune system to attack cancer cells.